Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MTCR
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Metacrine Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Market cap
- 19.63M
- Ent value
- -15.15M
- Price/Sales
- -
- Price/Book
- 0.53
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -47.69%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
MTCR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.53 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 43.83M |
| EPS (TTM) | -0.90 |
| FCF per share (TTM) | -1.17 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -36.53M |
| Net income (TTM) | -38.19M |
| EPS (TTM) | -0.90 |
| EPS (1y forward) | -0.09 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 52.75M |
| Net receivables | 55.00K |
| Total current assets | 55.04M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 55.04M |
| Accounts payable | 691.00K |
| Short/Current long term debt | 13.79M |
| Total current liabilities | 4.53M |
| Total liabilities | 17.97M |
| Shareholder's equity | 37.06M |
| Net tangible assets | 37.06M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -49.92M |
| Capital expenditures (TTM) | 8.00K |
| Free cash flow (TTM) | -49.92M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -103.03% |
| Return on Assets | -69.39% |
| Return on Invested Capital | -75.10% |
| Cash Return on Invested Capital | -98.17% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| MTCR | S&P500 | |
| Current price drop from All-time high | -96.08% | -4.34% |
| Highest price drop | -96.95% | -56.47% |
| Date of highest drop | 24 Oct 2022 | 9 Mar 2009 |
| Avg drop from high | -81.23% | -11.07% |
| Avg time to new high | 111 days | 12 days |
| Max time to new high | 979 days | 1805 days |
COMPANY DETAILS
Marketcap
19.63M
Marketcap category
Small-cap
Description
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Employees
10
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner